Digital Look

Welcome to Digital Look++,
you are not logged in

Oncimmune Holdings (ONC)

15.15p

Select chart: EPS | Dividend | Revenue

Period Ending	Period	Revenue (£m)	Pre-tax (£m)	EPS	Dividend
29-Feb-24	Interim	1.19	(1.11)	(0.01)p	n/a

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-May-19	0.17	(8.55)	(12.97)p	n/a	n/a	n/a	n/a	0.0%
31-May-20	0.51	(9.78)	(13.36)p	n/a	n/a	n/a	n/a	0.0%
31-May-21	3.72	(6.06)	(7.73)p	n/a	n/a	n/a	n/a	0.0%
31-Aug-22	2.32	(6.58)	(7.91)p	n/a	n/a	n/a	n/a	0.0%
31-Aug-23	1.15	(5.93)	(8.47)p	n/a	n/a	n/a	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Aug-24	2.80	(2.60)	(4.30)p	n/a	n/a	n/a	n/a	0.0%
31-Aug-25	6.90	0.50	0.20p	75.8	n/a	n/a	n/a	0.0%

	5 Yr High	5 Yr Low	5 Yr Avg	Curr / Avg
Latest	n/a	n/a	n/a	0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

Find out about IFRS and how this affects the financial infomation for all UK companies.